BackInovio Pharmaceuticals Overview

Inovio Pharmaceuticals Receivables

Inovio Pharmaceuticals's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-840312.00 vs prior year quarter

Peer trimmed avg / median

Loading

Inovio Pharmaceuticals Receivables History

Loading

Inovio Pharmaceuticals vs. peers: Receivables Comparison

Loading

Inovio Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Inovio Pharmaceuticals (GBMB.F) FAQ

The latest receivables for GBMB.F is $0 as of June 2026. That compares with $840K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Inovio Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, GBMB.F's receivables moved from $840K to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Inovio Pharmaceuticals's operating scale or balance-sheet position.

A receivables figure of $0 for GBMB.F is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GBMB.F's receivables ($0), review year-over-year change from $840K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Inovio Pharmaceuticals's receivables against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.